Automate Your Wheel Strategy on NAOV
With Tiblio's Option Bot, you can configure your own wheel strategy including NAOV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NAOV
- Rev/Share 4.827
- Book/Share 83.5325
- PB 0.0703
- Debt/Equity 0.0525
- CurrentRatio 1.0533
- ROIC -0.1755
- MktCap 4677727.0
- FreeCF/Share -12.6278
- PFCF -0.7645
- PE -0.5599
- Debt/Assets 0.0413
- DivYield 0
- ROE -0.2584
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
NanoVibronix Announces Results from UroShield™ Case Series
Published: May 12, 2025 by: Business Wire
Sentiment: Neutral
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in therapeutic devices, today announced findings from a recent retrospective case series evaluating the clinical impact and patient experience of the UroShield™ system. The case series, conducted between September 2023 and January 2025 by researchers at University Hospitals Coventry and Warwickshire Partnership NHS, assessed a small group of patients who used the UroShield.
Read More
About NanoVibronix, Inc. (NAOV)
- IPO Date 2015-05-28
- Website https://www.nanovibronix.com
- Industry Medical - Devices
- CEO Brian M. Murphy
- Employees 31